1. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
    Nicola Antonio di Meo et al, 2023, Expert Review of Molecular Diagnostics CrossRef
  2. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
    Sahar Rezaei et al, 2023, European Journal of Pharmacology CrossRef
  3. MeCP2-Induced Alternations of Transcript Levels and m6A Methylation in Human Retinal Pigment Epithelium Cells
    Xueru Zhao et al, 2023, ACS Omega CrossRef
  4. ELOVL2 restrains cell proliferation, migration, and invasion of prostate cancer via regulation of the tumor suppressor INPP4B
    Tengfei Hu et al, 2022, Cellular Signalling CrossRef
  5. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
    Xiaohui Wang et al, 2023, World Journal of Surgical Oncology CrossRef
  6. Fatty acids in cancer: Metabolic functions and potential treatment
    Ao Du et al, 2023, MedComm – Oncology CrossRef
  7. Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma
    Yankun Gao et al, 2023, BMC Cancer CrossRef
  8. ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
    Satoshi Nitta et al, 2022, Cancer Science CrossRef
  9. Lipids as mediators of cancer progression and metastasis
    Felix C. E. Vogel et al, 2024, Nature Cancer CrossRef
  10. The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation
    Xingyu Gao et al, 2023, Frontiers in Pharmacology CrossRef
  11. Expression of decitabine-targeted oncogenes in meningiomas in vivo
    Julian Canisius et al, 2022, Neurosurgical Review CrossRef
  12. Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
    Sergiu Chira et al, 2022, Cells CrossRef
  13. Ten Years of CRISPRing Cancers In Vitro
    Davide Capoferri et al, 2022, Cancers CrossRef